Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Bitterly cold arctic air has blanketed parts of the United States over the last week, with some areas getting snow and subzero temperatures. Along with the cold weather comes a natural event called ...

Joshua Tree National Park is often described as an out-of-this-world experience or healing for one’s soul, says Donovan Smith, the park’s public information officer. “With blue sunny skies almost year ...